1. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases. Issue 9 (10th June 2019) Authors: Bachet, J.‐B.; Moreno‐Lopez, N.; Vigano, L.; Marchese, U.; Gelli, M.; Raoux, L.; Truant, S.; Laurent, C.; Herrero, A.; Le Roy, B.; Deguelte Lardiere, S.; Passot, G.; Hautefeuille, V.; De La Fouchardiere, C.; Artru, P.; Ameto, T.; Mabrut, J. Y.; Schwarz, L.; Rousseau, B.; Lepère, C. Journal: British journal of surgery Issue: Volume 106:Issue 9(2019) Page Start: 1237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. What is the best strategy for a curative treatment of synchronous colorectal liver metastases?. (September 2018) Authors: Maulat, C.; Raoux, L.; Al Ali, A. Hantoush; Dousse, D.; Fares, N.; Guimbaud, R.; Selves, J.; Mokrane, F.-Z.; Suc, B.; Muscari, F. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗